Get 20M+ Full-Text Papers For Less Than $1.50/day. Start a 14-Day Trial for You or Your Team.

Learn More →

Should liver metastases of breast cancer be biopsied to improve treatment choice?

Should liver metastases of breast cancer be biopsied to improve treatment choice? Currently, the acquisition of tissue from metastatic deposits is not recommended as a routine practice. Our aim was to evaluate the discordance rate of estrogen receptor (ER), progesterone receptor (PgR), and human epidermal growth factor receptor 2 (HER2) receptor status between primary tumor and liver metastases and its potential impact on treatment choice. http://www.deepdyve.com/assets/images/DeepDyve-Logo-lg.png Annals of Oncology Pubmed

Should liver metastases of breast cancer be biopsied to improve treatment choice?

Should liver metastases of breast cancer be biopsied to improve treatment choice?


Abstract

Currently, the acquisition of tissue from metastatic deposits is not recommended as a routine practice. Our aim was to evaluate the discordance rate of estrogen receptor (ER), progesterone receptor (PgR), and human epidermal growth factor receptor 2 (HER2) receptor status between primary tumor and liver metastases and its potential impact on treatment choice.

Loading next page...
 
/lp/pubmed/should-liver-metastases-of-breast-cancer-be-biopsied-to-improve-cZZCIe9jtH

References (42)

ISSN
0923-7534
DOI
10.1093/annonc/mdq751
pmid
21343379
Publisher site
See Article on Publisher Site

Abstract

Currently, the acquisition of tissue from metastatic deposits is not recommended as a routine practice. Our aim was to evaluate the discordance rate of estrogen receptor (ER), progesterone receptor (PgR), and human epidermal growth factor receptor 2 (HER2) receptor status between primary tumor and liver metastases and its potential impact on treatment choice.

Journal

Annals of OncologyPubmed

Published: Dec 12, 2011

There are no references for this article.